Diplomat Pharmacy Inc (DPLO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
November 2018
48
About the Report
About the Report
Summary
Diplomat Pharmacy Inc (Diplomat Pharmacy) is a specialty pharmacy services provider that offers personalized medication therapies and various other clinical services. It also provides pharmacy benefit management and customized care management solutions, including dispensing, delivery, dosing, and reimbursement of clinically intensive and high-cost specialty drugs. The company is licensed to dispense prescriptions in all the US states and territories. Diplomat Pharmacy's solutions include patient care system, clinically based drug therapy management programs, counseling on adherence and side-effect management, drug-specific compliance programs, and clinical and administrative support services. It also provides financial assistance to patients and Hub Services for maintaining collaboration among participants in the specialty pharmacy system. Through Diplomat University, the company provides training to external professionals, including pharmacists, payors, pharmaceutical partners, and physicians, on the specialty pharmacy industry. Diplomat Pharmacy is headquartered in Flint, Michigan, the US.
Diplomat Pharmacy Inc (DPLO)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Products
Products
Diplomat Pharmacy Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Table of Contents
Table of Contents
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Diplomat Pharmacy Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Diplomat Pharmacy Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Diplomat Pharmacy Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Diplomat Pharmacy Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Diplomat Pharmacy Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Diplomat Pharmacy Inc, Pharmaceuticals & Healthcare, Deal Details 10
Equity Offering 10
Diplomat Pharmacy Raises USD198 Million in Public Offering of Shares 10
Diplomat Pharmacy Raises USD143 Million in IPO 12
Acquisition 13
Diplomat Pharmacy Acquires Burman's Specialty Pharmacy for USD82.8 13
Diplomat Pharmacy Acquires BioRx 14
Diplomat Pharmacy Acquires MedPro Rx, Infusion Provider 16
Diplomat Pharmacy Inc-Key Competitors 17
Diplomat Pharmacy Inc-Key Employees 18
Diplomat Pharmacy Inc-Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 21
Financial Announcements 21
Aug 06, 2018: Diplomat announces 2nd quarter financial result 21
May 07, 2018: Diplomat Announces Strong 1st Quarter Financial Results 23
Feb 26, 2018: Diplomat Announces 4th Quarter and 2017 Year End Financial Results; Provides 2018 Guidance 25
Nov 06, 2017: Diplomat Announces Third Quarter Financial Results 27
Aug 07, 2017: Diplomat Announces Second Quarter Financial Results 29
May 08, 2017: Diplomat Announces 1st Quarter Financial Results 31
Feb 28, 2017: Diplomat Announces 4th Quarter and 2016 Year End Financial Results; Provides Initial 2017 Guidance 33
Jan 09, 2017: Diplomat Provides 2016 Financial Guidance Update 35
Corporate Communications 36
May 10, 2018: Diplomat Pharmacy Appoints Brian Griffin as Chief Executive Officer and Chairman of the Board 36
May 08, 2018: Diplomat Pharmacy in Final Stages of CEO Search Process 37
Jan 05, 2018: Diplomat Initiates CEO Transition; Reaffirms 2017 Guidance and Provides Preliminary 2018 Outlook 38
Aug 07, 2017: Diplomat Announces A New President 40
Jun 08, 2017: Jeff Park Elected to Diplomat Board of Directors 41
Apr 13, 2017: Diplomat Promotes Executive Jennifer Cretu 42
Apr 11, 2017: Diplomat Appoints New Chief Financial Officer 43
Apr 06, 2017: Dr. Regina Benjamin Appointed to Diplomat's Board of Directors 44
Feb 14, 2017: Diplomat Enhances Corporate Governance With Appointment of Ben Wolin to Newly-Created Role of Lead Director 45
Government and Public Interest 46
Feb 21, 2018: Diplomat Managing Rising Drug Costs to Support Patients 46
Other Significant Developments 47
Apr 30, 2018: Diplomat Launches CastiaRx Industry-Leading Specialty Benefit Manager 47
Appendix 48
Methodology 48
About GlobalData 48
Contact Us 48
Disclaimer 48
List of Figure
List of Figures
Diplomat Pharmacy Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Diplomat Pharmacy Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Diplomat Pharmacy Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Diplomat Pharmacy Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Diplomat Pharmacy Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Diplomat Pharmacy Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Diplomat Pharmacy Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Diplomat Pharmacy Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
List of Table
List of Tables
Diplomat Pharmacy Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Diplomat Pharmacy Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Diplomat Pharmacy Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Diplomat Pharmacy Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Diplomat Pharmacy Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Diplomat Pharmacy Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Diplomat Pharmacy Raises USD198 Million in Public Offering of Shares 10
Diplomat Pharmacy Raises USD143 Million in IPO 12
Diplomat Pharmacy Acquires Burman's Specialty Pharmacy for USD82.8 13
Diplomat Pharmacy Acquires BioRx 14
Diplomat Pharmacy Acquires MedPro Rx, Infusion Provider 16
Diplomat Pharmacy Inc, Key Competitors 17
Diplomat Pharmacy Inc, Key Employees 18
Diplomat Pharmacy Inc, Other Locations 19
Diplomat Pharmacy Inc, Subsidiaries 19
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.